Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for MAZE THERAPEUTICS, INC. Common Stock (MAZE).
- Disclosed ownership: 7.3%.
- Date of event: 30 Sep 2025.
JANUS HENDERSON GROUP PLC - 30 Sep 2025 SCHEDULE 13G/A Report for MAZE THERAPEUTICS, INC. Common Stock (MAZE)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Security
- MAZE THERAPEUTICS, INC. Common Stock
- Symbol
- MAZE
- Shares outstanding
- 43,924,274 shares
- Disclosed Ownership
- 3,206,472 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 12:49:29 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 7.3% ownership in MAZE THERAPEUTICS, INC. Common Stock (MAZE) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 14 Nov 2025, 12:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.3% | 3,206,472 | 0 | 3,206,472 | Kristin Mariani | Head of North America Compliance, CCO |